Enavate Sciences invests in and supports the growth of therapeutic and enabling technology companies focused on developing novel treatments and medical devices. The firm addresses the need for funding and strategic guidance in a sector that often struggles with resource allocation and market entry challenges.
Funding
$300M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Therapeutic and enabling technology companies often face challenges in securing adequate funding and strategic support, hindering their ability to develop novel treatments and medical devices and navigate market entry complexities. This scarcity of resources can delay or prevent the advancement of promising innovations in the life sciences sector.
Solution
Enavate Sciences is a platform that invests in and supports the growth of therapeutic and enabling technology companies focused on developing novel treatments and medical devices. The company provides capital and strategic growth support to innovative companies, enabling them to advance and accelerate the development of novel therapies with the goal of improving patients’ health and quality of life. Enavate Sciences assembles a team of professionals to support its portfolio companies in key functions of company building, including drug discovery and development, clinical and market assessments, and business development.
Target Audience
Enavate Sciences targets innovative therapeutic and enabling technology companies in the life sciences sector, particularly those developing novel treatments and medical devices.
Features
- Capital investment in therapeutic and enabling technology companies
- Strategic growth support to accelerate innovation
- Expertise in drug discovery and development
- Assistance with clinical and market assessments
- Business development support
- Focus on companies with transformative potential to address patient needs